<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04617418</url>
  </required_header>
  <id_info>
    <org_study_id>SB&amp;EM</org_study_id>
    <nct_id>NCT04617418</nct_id>
  </id_info>
  <brief_title>Smartphone Behavior and Epilepsy Management</brief_title>
  <official_title>Using Day-to-day Behavior on Smartphones to Improve Epilepsy Management</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stichting Epilepsie Instellingen Nederland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Leiden University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Stichting Epilepsie Instellingen Nederland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this prospective cohort study smartphone behavior surrounding epileptic seizures will be&#xD;
      quantified, using a smartphone app, in order to optimize epilepsy evaluation and treatment&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale:&#xD;
&#xD;
      The unpredictability of seizures and the unclear behavioral outcomes are major concerns for&#xD;
      people with epilepsy and may surface as increased anxiety about independence. This&#xD;
      unpredictability is also a true obstacle in capturing and studying seizure-related&#xD;
      neurobehavioral alterations themselves. Also, seizures often impact consciousness and thus&#xD;
      may go unnoticed. As a result, subjective seizure diaries are unreliable. Continuous&#xD;
      smartphone-based monitoring of behavioral output is a fast-emerging topic and proven fruitful&#xD;
      in monitoring other neurological disease states. In the field of epilepsy, these tools are&#xD;
      yet to be introduced.&#xD;
&#xD;
      Objective:&#xD;
&#xD;
      The investigators hypothesize that quantifying smartphone behavior will help obtain a&#xD;
      detailed and objective behavioral map of seizures that can complement existing subjective&#xD;
      seizure diaries and thereby improve the way epilepsy treatments are evaluated in daily&#xD;
      practice.&#xD;
&#xD;
      Study design:&#xD;
&#xD;
      A multicentre observational prospective cohort study with at least 3 months follow-up.&#xD;
&#xD;
      Study population:&#xD;
&#xD;
      100 subjects with refractory focal epilepsy with a seizure frequency of at least one per&#xD;
      month.&#xD;
&#xD;
      Main study parameters/endpoints:&#xD;
&#xD;
      Change in touchscreen interactions (tapping speed, texting speed, apps used, location,&#xD;
      sleep-wake cycles) surrounding reported epileptic seizures.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 3, 2020</start_date>
  <completion_date type="Anticipated">November 3, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 3, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in tapping speed surrounding reported epileptic seizures</measure>
    <time_frame>3 months</time_frame>
    <description>The tapping speed will be measured using the TapCounter app by QuantActions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in number of apps used surrounding reported epileptic seizures</measure>
    <time_frame>3 months</time_frame>
    <description>The number of apps used will be measured using the TapCounter app by QuantActions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in time spent using the smartphone surrounding reported epileptic seizures</measure>
    <time_frame>3 months</time_frame>
    <description>The phone usage in hours will be measured using the TapCounter app by QuantActions</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes in speed of unlocking the smartphone surrounding reported epileptic seizures</measure>
    <time_frame>3 months</time_frame>
    <description>The unlocking speed will be measured using the TapCounter app by QuantActions</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery after seizure</measure>
    <time_frame>3 months</time_frame>
    <description>See how long does it take to behaviorally recover after a seizure, this will be assessed using the TapCounter app and seeing when phone usage before and after the reported seizure are similar again</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of seizures in diaries and seizures in app use</measure>
    <time_frame>3 months</time_frame>
    <description>See if reported seizure incidence matches with seizure incidence deducted from smartphone measurements</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subgroup analysis</measure>
    <time_frame>3 months</time_frame>
    <description>Analyze differences in behavioural patterns between individuals with different types of epilepsy (e.g. different seizure types or onset zones)</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>subjects with refractory focal epilepsy with a seizure frequency</arm_group_label>
    <description>The investigators will include 100 subjects with refractory focal epilepsy with a seizure frequency of at least one per month, and ask them to keep a seizure diary and use the TapCounter app for three months.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Change in touchscreen interactions</intervention_name>
    <description>The investigators will measure the changes in touchscreen interactions using the TapCounter app by QuantActions</description>
    <arm_group_label>subjects with refractory focal epilepsy with a seizure frequency</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        100 subjects with refractory focal epilepsy with a seizure frequency of at least one per&#xD;
        month.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ≥ 18 years of age&#xD;
&#xD;
          -  diagnosed with refractory focal epilepsy&#xD;
&#xD;
          -  have a seizure frequency of ≥ 1 per month&#xD;
&#xD;
          -  only one seizure type, or in case of multiple seizure types only seizures that&#xD;
             correspond to one probable onset zone (e.g. focal and focal to bilateral tonic-clonic&#xD;
             seizures)&#xD;
&#xD;
          -  have daytime seizures (exclusively or both daytime and night-time seizures)&#xD;
&#xD;
          -  those with at least one seizure that has been recorded during a video-EEG, or those&#xD;
             who undergo a presurgical evaluation during the study period including a video-EEG&#xD;
             recording with tapering of antiseizure medication&#xD;
&#xD;
          -  mentally competent and with no learning disabilities&#xD;
&#xD;
          -  able to keep a seizure diary including time and date (as judged by the treating&#xD;
             physician)&#xD;
&#xD;
          -  have an Android-operating smartphone&#xD;
&#xD;
          -  use their phone with at least 5 distinct smartphone apps at a minimum of 5 days a week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  not fulfilling the above mentioned inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roland D Thijs, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Stichting Epilepsie Instellingen Nederland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Johanna W Bunschoten</last_name>
    <phone>+31235588143</phone>
    <email>hbunschoten@sein.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kempenhaeghe</name>
      <address>
        <city>Heeze</city>
        <state>Noord-Brabant</state>
        <zip>5591 VE</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Richard Lazeron, MD PhD</last_name>
      <email>LazeronR@Kempenhaeghe.nl</email>
    </contact>
    <investigator>
      <last_name>Richard Lazeron, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Stichting Epilepsie Instellingen Nederland</name>
      <address>
        <city>Heemstede</city>
        <state>Noord-Holland</state>
        <zip>2103 SW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Johanna W Bunschoten</last_name>
      <phone>+31235588143</phone>
      <email>hbunschoten@sein.nl</email>
    </contact>
    <investigator>
      <last_name>Roland D Thijs, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 28, 2020</study_first_submitted>
  <study_first_submitted_qc>November 4, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 5, 2020</study_first_posted>
  <last_update_submitted>August 17, 2021</last_update_submitted>
  <last_update_submitted_qc>August 17, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Epilepsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

